openPR Logo
Press release

Facial Injectable Market Detail Analysis focusing on Key Players like Merz, Inc., Galderma Laboratories, L.P., ColBar LifeScience Ltd., Allergan, Plc., Valeant Pharmaceuticals North America LLC., Sanofi Biosurgery Inc. (Sanofi), Anika Therapeutics, Inc.,

10-14-2018 03:57 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Facial Injectable Market Size, Facial Injectable Market Share, Facial Injectable Market Trends

Facial Injectable Market Size, Facial Injectable Market Share, Facial Injectable Market Trends

Facial injectable products also called as dermal fillers are products that benefit in facial transformation. These facial injectable products are widely used to indulgence the early signs of age as well as wrinkles thereby increasing the visual attractiveness.

The Global Facial Injectable Market was estimated at USD 7,126.65 Million in 2017 and is anticipated to gain significant traction over coming years.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/request-for-free-sample

Factors such as the rise in demand to augment the visual look and growing popularity for negligibly intrusive procedures majorly drive the market. In addition, the rise in elderly population and introduction of improved facial injectable such as synthetic calcium hydroxyl apatite fillers further anticipated boosting the market growth. In recent time, growing demand for non-surgical processes for facial transformation and modification is gaining global admiration. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2017, non-surgical and surgical cosmetic techniques showed an overall rise of 9% from past years. Moreover, according to the same report in 2016, nonsurgical procedures including injectable accounted for approximately 8 million globally.

Make an inquiry for purchasing this report @ https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/inquire-before-buying

The global Facial Injectable Market is segmented on the basis of products, end users, and geography.

On the basis of products, the Global Facial Injectable Market is segmented into Dermal Fillers/Injectable Implants and Anti-aging/ Anti-wrinkle Injections. The Dermal Fillers/Injectable Implants is further segmented into Hyaluronic Acid, Collagen Fillers, and Synthetic Fillers such as Calcium hydroxylapatite and polymethyl methacrylate microspheres. The Anti-aging/ Anti-wrinkle Injections is further categorized into Botulinum toxin A and Poly-L-lactic acid (PLLA) micro particles. On the basis of products, the hyaluronic acid segment is estimated to dominate the market in 2017. Moreover, this segment is anticipated to show lucrative growth during the forecast period.

Cumulative use of hyaluronic acid as a dermal filler in the cosmetic procedure is anticipated to support the market growth. Hyaluronic acid has become an important part of cosmetics and aesthetic surgeries due to its robust water retaining properties. In general, the cosmetic-grade hyaluronic acid has the lower molecular weight which further aids to retain water in the cells, releases antioxidants, form the deep penetration of the product in the epidermis, and delays the aging progression.

On the basis of the end user, the global Facial Injectable Market is segmented into Hospitals, Dermatology Clinics, Beauty Clinics, and Dermatology Research Institutes. In 2017, hospital segment is estimated to dominate the global market.

Complete Report Details @ https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/

Top Key Player:-

Advanced Dermatology
Merz, Inc.
Galderma Laboratories, L.P.
ColBar LifeScience Ltd.
Allergan, Plc.
Valeant Pharmaceuticals North America LLC.
Sanofi Biosurgery Inc. (Sanofi)
Anika Therapeutics Inc.
Suneva Medical Inc.

About us Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

We mainly focus on aiding our customers with substantial competitive intelligence, helping them to secure a competitive advantage in the market and accomplish sustainable growth in different market domains. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Through dedicated qualitative and quantitative primary and secondary market research and consulting assignments, we adeptly formulate competitive strategies to address business challenges for our clients through analyzing market trends and emerging technologies.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Facial Injectable Market Detail Analysis focusing on Key Players like Merz, Inc., Galderma Laboratories, L.P., ColBar LifeScience Ltd., Allergan, Plc., Valeant Pharmaceuticals North America LLC., Sanofi Biosurgery Inc. (Sanofi), Anika Therapeutics, Inc., here

News-ID: 1301885 • Views:

More Releases from Polaris Market Research & Consulting

Asia Pacific Polyurethane Market Sets New Record, Projected at US$ 59.45 Billion by 2032 at 5.6% CAGR
Asia Pacific Polyurethane Market Sets New Record, Projected at US$ 59.45 Billion …
New York, April 28, 2024 (Polaris Market Research) According to a research report "Asia Pacific Polyurethane Market by Product (Rigid PU Foam, Flexible PU Foam, PU Coatings, PU Adhesives & Sealants, PU Elastomers), Application, Country - Global Forecast to 2032" published by Polaris Market Research, the market size for polyurethane in Asia Pacific is projected to reach approximately USD 59.45 billion by 2032, as compared to the estimated value of
Europe Transcritical CO2 Market Size to Hit US$ 94.20 Billion by 2032, Grow at a 15.3% CAGR
Europe Transcritical CO2 Market Size to Hit US$ 94.20 Billion by 2032, Grow at a …
New York, April 28, 2024 (Polaris Market Research) The Europe Transcritical CO2 Market, in terms of revenue, was estimated to be worth USD 26.26 billion in 2023 and is foreseen to reach USD 94.20 billion by 2032, growing at a CAGR of 15.3% from 2024 to 2032, according to a recent report by Polaris Market Research. Growing demand in the refrigeration industry for natural refrigerants and energy-efficient solutions is propelling
Asia Pacific Energy Drinks Market Exceed US$ 68.77 Billion and Exhibit at a CAGR of 7.4% in the Year 2032
Asia Pacific Energy Drinks Market Exceed US$ 68.77 Billion and Exhibit at a CAGR …
Asia Pacific Energy Drinks Market size and share is currently valued at USD 36.44 billion in 2023 and is anticipated to generate an estimated revenue of USD 68.77 Billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.4% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032 This is due to several factors, including growing
Battery Energy Storage System Market Predicted to Grow Expeditiously to Surpass US$ 54,340.12 Million During 2024-2032
Battery Energy Storage System Market Predicted to Grow Expeditiously to Surpass …
New York, April 28, 2024 (Polaris Market Research) Global Battery Energy Storage System Market size and share is currently valued at USD 6,463.09 million in 2023 and is anticipated to generate an estimated revenue of USD 54,340.12 Million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 26.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024

All 5 Releases


More Releases for Injectable

Injectable Sumatriptan Market 2021 | Detailed Report
ReportsnReports publishes the report titled Injectable Sumatriptan that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis. The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics
Global Injectable Drug Delivery Market to 2028 |Retail Pharmacies, Injectable Dr …
Market Research Hub (MRH) has carefully analyzed this research study titled Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028, which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Injectable Drug Delivery. Readers can gain knowledge related to prime
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Injectable Targeted Therapy Market: Primary application of injectable targeted t …
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of